By John Lee.
International aesthetics company Sinclair Pharma has said it has seen strong growth in Iran.
In an unaudited trading update, the UK-based company said:
“Ellansé delivered revenues of £9.6 million compared to £8.1 million in the prior year representing growth of 18% (10% at constant currency). This reflected strong growth in many markets, especially Spain, Mexico, and Iran.
“Perfectha revenues were £9.4 million against £8.1 million in 2016, growth of 16% (10% at constant currency). Strong demand by distributors in South Korea, Iran and Mexico were the main contributors to this performance.“
(Source: Sinclair Pharma)
No comments yet.